CVS Health Raises 2022 Adjusted Earnings Guidance
02 Novembro 2022 - 8:22AM
Dow Jones News
By Will Feuer
CVS Health Corp. cut its full-year earnings guidance to reflect
opioid-settlement charges incurred in the recently ended quarter as
well as other charges, but raised its 2022 guidance for earnings on
an adjusted basis.
The Woonsocket, R.I.-based company said it now expects full-year
earnings of $3.12 a share to $3.22 a share, down from prior
guidance of $7.23 a share to $7.43 a share.
Adjusted earnings, which exclude one-time items, including the
charges tied to the opioid settlements, are now expected to be
between $8.55 a share and $8.65 a share for the year, up from a
prior range of $8.40 a share to $8.60 a share.
The company also raised its full-year cash flow from operations
guidance range to $13.5 billion to $14.5 billion, from $12.5
billion to $13.5 billion.
In addition to the opioid charges, the company said the
adjustments also reflect amortization, losses on assets held for
sale and the gain on the sale of PayFlex Holdings Inc.
Shares of CVS rose almost 5% in premarket trading to $99.30.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
November 02, 2022 07:07 ET (11:07 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
CVS Health (NYSE:CVS)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024